A mossy renaissance

By Katherine Bagley A mossy renaissance Protonema cells of Physcomitrella patens The world’s top moss researchers—all eight of them—were gathered in a college lecture hall in Freiburg, Germany when they found out they had been granted funding to sequence a common moss (Physcomitrella patens) genome. It was September 2004, just a year after the group had made a joint decision to increase the moss field’s visibility. The moss field

Written byKatherine Bagley
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The world’s top moss researchers—all eight of them—were gathered in a college lecture hall in Freiburg, Germany when they found out they had been granted funding to sequence a common moss (Physcomitrella patens) genome. It was September 2004, just a year after the group had made a joint decision to increase the moss field’s visibility. The moss field wasn’t getting enough respect, the researchers believed, and they wanted to do something about it.

“Our group had decided we needed to accomplish two things to get our science into people’s living rooms: publish more high-profile papers and create concrete applications for our research,” says Ralph Quatrano, a plant biologist at Washington University in St. Louis. “To us, sequencing the genome was the best way to accomplish those goals.”

The coalition’s strategy to sequence and disseminate the genome, set up that day in a University of Freiburg lecture hall, has thrust the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies